Zimbabwe becomes first African nation to approve HIV prevention drug

World Health Organization welcomes country's crucial step' in backing use of long-acting injectable cabotegravir (CAB-LA)

Zimbabwe has become the first country in Africa and the third in the world to approve an HIV prevention drug recently recommended by the World Health Organization (WHO).

Regulators in Australia and the US have already given their backing to use the long-acting injectable cabotegravir (CAB-LA), and the WHO welcomed the move by Zimbabwe.